# Spinal Kinetics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spinal-kinetics

- Industry: Medical Devices & Equipment
- Headquarters: Sunnyvale, US
- Website: www.spinalkinetics.com
- Total disclosed funding: $68M
- Latest round: Series C (May 20, 2014)
- Investors on record: 7

## About

Spinal Kinetics, Inc. specializes in developing innovative orthopedic and spinal solutions, including advanced artificial discs that replicate the natural mechanics of healthy vertebral discs, addressing critical needs in cervical disc replacement surgery.Founded in 2003 in Sunnyvale, US, Spinal Kinetics, Inc. focuses on spinal solutions, notably the M6-C™ Artificial Cervical Disc. The company was acquired by Orthofix International N.V. in March 2018 for USD 45.00 mn with potential additional payments of up to USD 60.00 mn. Jeffrey Cronk serves as the CEO.Spinal Kinetics, Inc. offers advanced orthopedic and spinal solutions, prominently featuring the M6-C™ Artificial Cervical Disc. This product is designed to emulate the functionality of natural vertebral discs, enhancing patient outcomes in cervical disc replacement procedures. Their offerings are distributed across various healthcare providers, including hospitals and clinics in the United States, Europe, Asia, and Latin America.The company generates revenue primarily from the sale of its medical devices, especially in the spinal and orthopedic sectors, through direct sales to healthcare providers and partnerships with distributors. The pricing of their flagship product, the M6-C Artificial Cervical Disc, aligns with market standards, emphasizing the advanced technology and clinical effectiveness of their solutions.Following the acquisition by Orthofix International N.V. in March 2018, which was valued at USD 45.00 mn, Spinal Kinetics, Inc. plans to leverage its resources for developing new products and expanding into additional markets. The company will focus on launching innovative orthopedic solutions and plans to enhance its presence in both existing and new geographical regions, ensuring readiness for future market demands.

## Funding rounds

- Series C, May 20, 2014, $34M — De Novo Ventures, HLM Venture Partners, SV Health Investors, Scale Venture Partners, Lumira Ventures
- Series B, Jan 1, 2006, $24M — MVM Partners, De Novo Ventures, HLM Venture Partners, Scale Venture Partners, Canadian Medical Discoveries Fund Inc.
- Series A, May 10, 2004, $10M — De Novo Ventures, HLM Venture Partners, Scale Venture Partners

## Investors

- De Novo Ventures (https://capitalatlas.ai/funds/de-novo-ventures) — Series A, Series B, Series C
- HLM Venture Partners (https://capitalatlas.ai/funds/hlm-venture-partners) — Series A, Series B, Series C
- Scale Venture Partners (https://capitalatlas.ai/funds/scale-venture-partners) — Series A, Series B, Series C
- MVM Partners (https://capitalatlas.ai/funds/mvm-partners) — Series B
- Canadian Medical Discoveries Fund Inc. — Series B
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series C
- Lumira Ventures (https://capitalatlas.ai/funds/lumira-ventures) — Series C